101![National Cancer Institute/National Toxicology Program (NCI/NTP) Technical Reports that Are Not Included in Carcinogenic Potency Database (CPDB) 1. Test Agent Exclusions A. Particulate TR # 279 National Cancer Institute/National Toxicology Program (NCI/NTP) Technical Reports that Are Not Included in Carcinogenic Potency Database (CPDB) 1. Test Agent Exclusions A. Particulate TR # 279](https://www.pdfsearch.io/img/dded2e3b117c00eb192af25ad9cb7a40.jpg) | Add to Reading ListSource URL: toxnet.nlm.nih.govLanguage: English - Date: 2012-11-17 17:24:23
|
---|
102![Guide to the Screen Version of the Carcinogenic Potency Database This guide to the screen version of the CPDB plot is intended to describe each field in the plot and to facilitate use of the data. The same results are re Guide to the Screen Version of the Carcinogenic Potency Database This guide to the screen version of the CPDB plot is intended to describe each field in the plot and to facilitate use of the data. The same results are re](https://www.pdfsearch.io/img/e7df98b4bfb53cd6d0f6e9db66f09401.jpg) | Add to Reading ListSource URL: toxnet.nlm.nih.govLanguage: English - Date: 2012-11-17 17:24:23
|
---|
103![Xopenex® (levalbuterol HCl) Inhalation Solution Concentrate, 1.25 mg* *Potency expressed as levalbuterol PRESCRIBING INFORMATION DESCRIPTION: Xopenex (levalbuterol HCl) Inhalation Solution is a sterile, clear, colorless Xopenex® (levalbuterol HCl) Inhalation Solution Concentrate, 1.25 mg* *Potency expressed as levalbuterol PRESCRIBING INFORMATION DESCRIPTION: Xopenex (levalbuterol HCl) Inhalation Solution is a sterile, clear, colorless](https://www.pdfsearch.io/img/06da4c69c042051cd2552130a54bd08e.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-09-11 15:54:36
|
---|
104![High-potency statins linked to increased risk of diabetes Saskatchewan researchers part of drug safety network that finds risk in potent cholesterol-lowering drugs Saskatoon. For release at 10:00 a.m. CST on May 29, 2014 High-potency statins linked to increased risk of diabetes Saskatchewan researchers part of drug safety network that finds risk in potent cholesterol-lowering drugs Saskatoon. For release at 10:00 a.m. CST on May 29, 2014](https://www.pdfsearch.io/img/3d03469a4f88afc9eaaf8f5daa10cf77.jpg) | Add to Reading ListSource URL: hqc.sk.caLanguage: English - Date: 2014-05-29 10:35:56
|
---|
105![Appendix 1 - Preliminary Cumulative Hazard and Dose-response Assessment for Organophorus Pesticides: Determination of Relative Potency and Points of Departure for Cholinesterase Inhibition Appendix 1 - Preliminary Cumulative Hazard and Dose-response Assessment for Organophorus Pesticides: Determination of Relative Potency and Points of Departure for Cholinesterase Inhibition](https://www.pdfsearch.io/img/a36e8735f131ed3a01eba995d131a930.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2010-07-13 17:08:02
|
---|
106![Preliminary Cumulative Hazard and Dose-response Assessment for Organophorus Pesticides: Determination of Relative Potency and Points of Departure for Cholinesterase Inhibition Preliminary Cumulative Hazard and Dose-response Assessment for Organophorus Pesticides: Determination of Relative Potency and Points of Departure for Cholinesterase Inhibition](https://www.pdfsearch.io/img/53df25a2b81c73768d74bd7e685fddb4.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2010-07-13 17:08:03
|
---|
107![Appendix 1 - Preliminary Cumulative Hazard and Dose-response Assessment for Organophorus Pesticides: Determination of Relative Potency and Points of Departure for Cholinesterase Inhibition Appendix 1 - Preliminary Cumulative Hazard and Dose-response Assessment for Organophorus Pesticides: Determination of Relative Potency and Points of Departure for Cholinesterase Inhibition](https://www.pdfsearch.io/img/97b15523f19601267e6b64f0687677a0.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2010-07-13 17:08:15
|
---|
108![Cancer Potency Values - December 17, 2008 Cancer Potency Values - December 17, 2008](https://www.pdfsearch.io/img/7e7dd506fbc465f63c511840b4be9ae7.jpg) | Add to Reading ListSource URL: www.oehha.ca.govLanguage: English - Date: 2014-03-27 19:58:55
|
---|
109![ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL’ABRUZZO E DEL MOLISE “G.CAPORALE” TERAMO TESTING OF MONOVALENT BLUETONGUE VACCINE (SEROTYPE 2) FOR INNOCUITY, POTENCY AND ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL’ABRUZZO E DEL MOLISE “G.CAPORALE” TERAMO TESTING OF MONOVALENT BLUETONGUE VACCINE (SEROTYPE 2) FOR INNOCUITY, POTENCY AND](https://www.pdfsearch.io/img/c793084f82c3b728bfb929125ceac8ee.jpg) | Add to Reading ListSource URL: eubtnet.izs.itLanguage: English - Date: 2006-10-03 04:21:08
|
---|
110![IOF Knowle dge Center In Vitro Toxicology and Dermato-cosmetology IOF Knowle dge Center In Vitro Toxicology and Dermato-cosmetology](https://www.pdfsearch.io/img/45bf34ec2265558b6fd8eedac506bc50.jpg) | Add to Reading ListSource URL: vubtechtransfer.beLanguage: English - Date: 2013-05-27 03:43:37
|
---|